The home dialysis market continues to gain massive traction.
The opportunity could be in the billions of dollars for the market as this is part of the chronic disease category that represents nearly 80% of the 18% of the US’s GDP spend on healthcare. With all that said, there are still headwinds.
Patient education on renal disease, home setup of these systems, support structure both in the home and clinically, having a patient “self -stick” their fistula, and the safe space within the home setting are all challenges to solve.
You can watch other interviews and learn more about Life Science Intelligence’s upcoming summit, LSI USA ‘22 Emerging Medtech Summit, March 15-18, 2022 here: https://lnkd.in/gk7rrSG